Schizoaffective Disorders Completed Phase 2 / 3 Trials for Quetiapine (DB01224)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00297947High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective DisorderTreatment